Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008;10(1):42-6.
doi: 10.1208/s12248-007-9000-9. Epub 2008 Jan 25.

The pharmacokinetics and interactions of ivermectin in humans--a mini-review

Aránzazu González Canga  1 , Ana M Sahagún Prieto, M José Diez Liébana, Nélida Fernández Martínez, Matilde Sierra Vega, Juan J García Vieitez
Affiliations
Review

The pharmacokinetics and interactions of ivermectin in humans--a mini-review

Aránzazu González Canga et al. AAPS J. 2008.

Abstract

Ivermectin is an antiparasitic drug with a broad spectrum of activity, high efficacy as well as a wide margin of safety. Since 1987, this compound has a widespread use in veterinary medicine and it use has been extended in humans. Here we present a brief review of the information available regarding the pharmacokinetics and interactions of ivermectin in humans. Awareness of these characteristics could improve the clinical efficacy of Ivermectin. All Authors declare that they do not have any Conflict of interest and that the work is original. All Authors agree that the contents of the manuscript are confidential and will not be copyrighted, submitted, or published elsewhere (including the Internet), in any language, while acceptance by the Journal is under consideration.

PubMed Disclaimer

References

    1. Fisher M. H., Mrozik H. Chemistry. In: Campbell W. C., editor. Ivermectin and abamectin. New York: Springer; 1989. pp. 1–23.
    1. Steel J.W. Pharmacokinetics and metabolism of avermectins in livestock. Vet. Parasitol. 1993;48:45–77. doi: 10.1016/0304-4017(93)90143-B. - DOI - PubMed
    1. Lindley D. Merck’s new drug free to WHO for river blindness programme. Nature. 1987;329:752. - PubMed
    1. Winne M., Plaisier A. P., Alley E. S., et al. Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull. WHO. 2002;80:384–390. - PMC - PubMed
    1. Molyneux D. H., Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Ann. Trop. Med. Parasitol. 2002;96:15–40. doi: 10.1179/000349802125002374. - DOI - PubMed

MeSH terms

LinkOut - more resources